Gli autoanticorpi antinucleo, anti-dsDNA anti-ENA nei pazienti con artrite reumatoide o spondilite anchilosante in trattamento con infliximab Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab
暂无分享,去创建一个
L. Punzi | S. Todesco | U. Fiocco | A. Hoxha | A. Ruffatti | C. Botsios | P. Grypiotis | M. Podswiadek
[1] D. Baeten,et al. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. , 2005, Arthritis and rheumatism.
[2] P. Sarzi-Puttini,et al. Autoimmunity and Anti‐TNF‐α Agents , 2005 .
[3] D. Caspi,et al. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab , 2005, Autoimmunity.
[4] S. Rantapää-Dahlqvist,et al. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα , 2004, Annals of the rheumatic diseases.
[5] M. Fitzcharles,et al. Induction of autoantibodies during prolonged treatment with infliximab. , 2003, Journal of Rheumatology.
[6] E. Veys,et al. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. , 2003, Arthritis and rheumatism.
[7] H. Zeidler,et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial , 2002, The Lancet.
[8] D. Baeten,et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. , 2002, Arthritis and rheumatism.
[9] G. Panayi,et al. Cytokine pathways and joint inflammation in rheumatoid arthritis. , 2001, The New England journal of medicine.
[10] R N Maini,et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.
[11] T. Schaible,et al. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment , 1999, Annals of the rheumatic diseases.
[12] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[13] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[14] A. Cats,et al. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.
[15] N. Martinelli,et al. Anti-TNFα therapy in rheumatoid arthritis and autoimmunity , 2004, Rheumatology International.